Drug Safety Is Influenced More by Business Interests Rather Than Public Health

dc.contributor.authorLexchin, Joel
dc.date.accessioned2015-05-21T17:50:39Z
dc.date.available2015-05-21T17:50:39Z
dc.date.issued2011
dc.descriptionen_US
dc.description.abstractThe safety of pharmaceutical drugs in Canada is a concern. While Health Canada is given the power to measure safety and approve drugs, the process has its limits. There is a growing trend towards practicing “risk management” rather than the “precautionary principle” when drugs are approved. There is also a greater priority put on meeting the interest of drug companies compared to the potential harm to public health. “Progressive licensing” would allow for drugs to be assessed for safety even after it’s approved.en_US
dc.description.sponsorshipYork's Knowledge Mobilization Unit provides services and funding for faculty, graduate students, and community organizations seeking to maximize the impact of academic research and expertise on public policy, social programming, and professional practice. It is supported by SSHRC and CIHR grants, and by the Office of the Vice-President Research & Innovation. kmbunit@yorku.ca www.researchimpact.caen_US
dc.identifier00154
dc.identifier.citationLexchin, J. (2010). Drug safety and Health Canada. International Journal of Risk and Safety in Medicine, 22(1), 41-53.en_US
dc.identifier.urihttp://hdl.handle.net/10315/29213
dc.relationYork Universityen_US
dc.relation.urien_US
dc.rightsAttribution-Noncommercial-No Derivative Works 2.5 Canadaen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ca/en_US
dc.subjectHealthen_US
dc.subjectBusinessen_US
dc.subjectLawen_US
dc.titleDrug Safety Is Influenced More by Business Interests Rather Than Public Healthen_US
dc.typeResearch Summaryen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
00154.pdf
Size:
396.41 KB
Format:
Adobe Portable Document Format